{"nct_id":"NCT03368859","title":"A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine, Oxaliplatin and Bevacizumab","status":"TERMINATED","status_verified_date":"2021-01","start_date":"2018-03-20","start_date_type":"ACTUAL","primary_completion_date":"2019-12-18","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["ABBV"]}